CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 166 enrolled
Drug / intervention
Metformindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02498522
NCT02498522Early Ph 1Completed
CompareCT.gov

Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome

Ain Shams University·interventional·Posted Jul 15, 2015·Updated May 19, 2016

In Brief

A Early Phase 1 clinical trial evaluating Metformin for Polycystic Ovary Syndrome. Completed, enrolled 166 participants across 1 site.

Detailed Summary

The aim of this work is to study the effect of metformin use for reducing early pregnancy loss in pregnant patients with Polycystic ovary syndrome (PCOS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovary Syndrome
CountriesEgypt
Collaborators--

Timeline

Early Ph 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 15, 2015
Enrollment StartAug 1, 2015
Primary CompletionFeb 1, 2016
Study CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.0 years ago

Interventions

Metformindrug

83 patients will continue metformin until end of 1st trimester